Trials / Completed
CompletedNCT01943812
Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Peter Humaidan · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to compare two FET protocols by modifying the substituted FET cycle in order to maintain a higher ongoing positive pregnancy rate and thus reduce the early pregnancy loss. Hypothesis: adding GnRH-agonist to the substituted cycle in FET treatment reduces the early pregnancy loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Estradiol and progeterone | Estradiol and progesterone |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2019-04-01
- Completion
- 2020-04-01
- First posted
- 2013-09-17
- Last updated
- 2020-06-23
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01943812. Inclusion in this directory is not an endorsement.